| TRI
Sections |
 |
SENIOR
TRI INVESTIGATORS AND ADMINISTRATORS
Section
on Behavioral Interventions
 Kimberly
C. Kirby, Ph.D. is a psychologist with specialization in behavior
analysis and behavioral pharmacology. She received her doctorate from
the University of Kansas and completed postdoctoral training at Duke University
and the Johns Hopkins School of Medicine. She is a Fellow of the American
Psychological Association and on the Executive Committee for the division
on Psychopharmacology and Substance Abuse. She is also a full member of
the College on Problems of Drug Dependence and the Association for Behavior
Analysis. She has focused her research on behavioral treatments that improve
motivation for recovery and addressed issues related to drug abuse and
the family, and the involvement of religious communities in addiction
recovery. She has more than 70 publications in professional books, meeting
proceedings, and journals.
 Lois
Benishek, Ph.D. is a licensed counseling psychologist. Her research
involves counselor training, treatment fidelity, and the acceptability
of adaptations of empirically-supported interventions by substance abuse
treatment programs. She has a special interest in multicultural issues.
Dr. Benishek is an experienced counselor and clinical supervisor who has
a special interest in multicultural issues. She has also been employed
as the director of Temple University’s masters-level counseling
psychology program. Dr. Benishek has served on the editorial board of
Journal of Counseling and Development and is presently a member of the
Association for Women in Psychology Board of Directors/Implementation
Collective.
 MaryLouise
Kerwin, Ph.D. is a licensed psychologist and Board Certified
Behavior Analyst with specialized experience in parent training, child
maltreatment, and pediatric psychology. She received her doctoral degree
from the University of Notre Dame and completed her clinical training
at The Johns Hopkins School of Medicine/The Kennedy Krieger Institute.
Her professional experience includes extensive training and experience
in the design and delivery of behavioral treatments and interventions
for pediatric problems. Kerwin is a recipient of a National Research Service
Award from the National Institute on Drug Abuse awarded to the Department
of Psychiatry, University of Pennsylvania School of Medicine to fund training
with Dr. Kimberly Kirby at the Treatment Research Institute. Through her
three-year collaboration with TRI, Dr. Kerwin has developed expertise
in the design and delivery of community reinforcement interventions for
women with drug addiction and family members of individuals with drug
and alcohol problems. In addition, she has been investigating the use
of contingency management interventions delivered individually and in
a group format.
Clinical
Trials Network

George Woody, M.D., Principal Investigator: Dr. Woody
is a Professor in the Department of Psychiatry at the University of Pennsylvania.
Following a long career in the mental health and substance abuse fields,
his research began in 1971 at the Drug Dependence Treatment Unit of the
Philadelphia Veterans Affairs Medical Center (VAMC) and the University
of Pennsylvania where his overall interest became the efficacy of psychosocial
and pharmacological treatments for addiction; the relationship between
drugs of abuse, psychiatric symptoms, and treatment outcome; and on risk
factors for HIV infection among persons who abuse drugs and how risk can
be reduced. He has been an active participant in projects evaluating naltrexone
(in the U.S. and in Russia), psychotherapy and counseling for persons
with cocaine dependence, and buprenorphine for treatment of heroin addiction.
In 1999 he became the principal investigator of the Delaware Valley Node
of the National Institute on Drug Abuse Clinical Trials Network (CTN,
and in 2003, received a Senior Scientist award from the National Institute
of Drug Abuse to allow him to spend less time on clinical work and more
on research. Dr. Woody’s numerous accomplishments and affiliations
include authoring or co-authoring more than 200 publications and co-editing
Treatment Improvement Protocols on methadone maintenance published by
the U.S. Substance Abuse and Mental Health Administration. He helped develop
Addiction Treatment Practice Guidelines for the Department of Veterans
Affairs, is a member of research groups studying the abuse liability of
tramadol and prescription opioids, and is a founding member of the Board
of Addiction Psychiatry of the American Psychiatric Association.
|